WN
William Garrett Nichols
Chief Medical Officer

William Garrett Nichols insider trades: Candel Therapeutics (CADL) stock sales

Chief Medical Officer, Candel Therapeutics Last trade Jul 28, 2025 34 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2020
2
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where William reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 28, 2025CADL↓ Sell$7K
Jun 30, 2025CADL↓ Sell$4K
Mar 18, 2025CADL↓ Sell$397K
Jan 15, 2025CADL↓ Sell$75K
Jan 8, 2025CADL↓ Sell$89K
Nov 29, 2024CADL↓ Sell$63K
Jul 17, 2024CADL↓ Sell$70K
Jul 11, 2024CADL↓ Sell$58K
Feb 10, 2020CMRX↓ Sell$19K
Jan 7, 2020CMRX↓ Sell$66K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CADL insiders

Open-market trades in the last 12 months

About William Garrett Nichols's insider trades

William Garrett Nichols is Chief Medical Officer at Candel Therapeutics (CADL). Since Jan 7, 2020, William has reported no open-market purchases and 10 sales worth $849K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (17 filings), shares withheld for taxes (7 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CADL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.